Cyberkinetics Andara OFS Spinal Nerve Repair System To Launch By Year-End
This article was originally published in The Gray Sheet
Executive Summary
Cyberkinetics Neurotechnology Systems is gearing up to launch its Andara OFS spinal nerve repair system "as early as the fourth quarter" of this year, the firm says, pending approval of a humanitarian device exemption application announced Feb. 20
You may also be interested in...
NeuroMetrix/Cyberkinetics Joint Venture Focuses On Peripheral Nerve Repair
NeuroMetrix will help Cyberkinetics develop and commercialize a device to treat peripheral nerve injury based on the latter company's Andara OFS spinal nerve repair neurostimulation platform under a joint venture agreement announced Nov. 14
NeuroMetrix/Cyberkinetics Joint Venture Focuses On Peripheral Nerve Repair
NeuroMetrix will help Cyberkinetics develop and commercialize a device to treat peripheral nerve injury based on the latter company's Andara OFS spinal nerve repair neurostimulation platform under a joint venture agreement announced Nov. 14
Financings In Brief
Cyberkinetics private placement to fund Andara OFS launch: Private placement raises $10 mil. to support a planned 2007 launch of the firm's Andara OFS oscillating field stimulator. The device received a humanitarian use device designation on Sept. 6, and is designed to promote nerve fiber regeneration in patients with recent spinal cord injuries, thereby improving or restoring tactile sensation and some movement in patients with quadriplegia and tetraplegia. Contingent upon FDA humanitarian device exemption (HDE) approval, a "limited" launch is expected next year (1"The Gray Sheet" Sept. 11, 2006, In Brief)...